Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Steinman: Dendritic Cells & Flavivirus Vectors |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2010-03-02 |
| Study Made Public: | 2010-12-16 |
Title
Neutralization activity of sera collected from mice immunized with DC-targeted SIV gag protein plus AT-2 inactivated SIV
Description
CAVD 322 is a preclinical mouse study to see if primed SIV gag-specific T cells would help generate a neutralizing antibody response to SIV envelope in mice immunized with two doses of a DC-targeted SIV protein gag p27 based vaccine to induce SIV gag p27 specific help.
Sign in to see full information about this study and to download study data.
Products
Poly ICLC AT-2 SIV DEC-SIV gagIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.